Renovaro receives Nasdaq non-compliance notice for annual meeting; granted extension to Oct 31, 2025

Lunai Bioworks Inc.

Received Nasdaq notice on July 7, 2025 for failure to comply with Listing Rule 5620(a) requiring annual shareholder meeting.
Nasdaq accepted compliance plan on August 5, 2025 and granted extension until October 31, 2025 to hold meeting.
Company intends to hold annual meeting within the extension period to regain compliance with listing standards.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.